Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Interferon-gamma production in the bone marrow of myelodysplastic syndrome patients supports a treg-independent immune-tolerant microenvironment

View Full Paper
Ask AI
Bookmark
Share

Authors

MCMarilena CiciarelloFGF. GirottiFZFederico Zingarelli

Discussion

Loading...

Member takes

Overview

Findings reveal a tolerogenic microenvironment driven by interferon in MDS, indicating unique immune-tolerant mechanisms.

Key Points

  • Increased IFN-γ levels in myelodysplastic syndrome shape the bone marrow microenvironment, promoting tolerance.
  • MDS samples exhibit distinct IFN-γ levels compared to acute myeloid leukemia, highlighting their immune landscape differences.
  • Analysis demonstrated that interferon production contributes to IDO1 upregulation, but MDS Treg induction pathways differ from AML.
  • The findings underscore the necessity to dissect immune factors in MDS for improved risk stratification and treatment strategies.

Cite This Study

Ciciarello et al. (2025) studied this question.

synapsesocial.com/papers/69362f3d4fa91c937236d529https://doi.org/10.1182/blood-2025-7360
View Full Paper
Ask AI
Bookmark
Share